GO
Loading...

Lightning Round OT: Immunogen, Synchronoss Tech and More

Friday, 8 Jan 2010 | 9:17 PM ET

Immunogen : “I think it’s going to have a big year,” Cramer said of IMGN. He likes it as a speculative play on biotech.

Lightning Round OT
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.

Synchronoss Technologies : “It just had a very big move,” Cramer said, so investors should take profits.

Hi Tech Pharmacal : Cramer is bullish on HITK, he said, even at these price levels.

















Call Cramer: 1-800-743-CNBC

Questions for Cramer? madmoney@cnbc.com

Questions, comments, suggestions for the Mad Money website? madcap@cnbc.com

  Price   Change %Change
HITK
---
IMGN
---
SNCR
---

Contact Mad Money

  • Showtimes

    Monday - Friday 6p ET
  • Jim Cramer is host of CNBC's "Mad Money" and co-anchor of the 9 a.m. ET hour of CNBC's "Squawk on the Street."

Mad Money Features

  • Grab the latest CNBC gear from the NBCUniversal Store!

  • Get a behind-the-scenes look at how Cramer formulates his investment advice. "Inside the Madness" is a column, which features e-mails and more with Cramer and his researcher Nicole Urken.

  • You’ve always wanted to hit the “Hallelujah!” button. Here’s your chance.